Accepted for Publication: May 10, 2021.
Published Online: October 4, 2021. doi:10.1001/jamapediatrics.2021.2320
Corresponding Author: Lucinda Rachel Grummitt, BA, National Health and Medical Research Council Centre of Research Excellence in PREMISE, The Matilda Centre for Research in Mental Health and Substance Use, The University of Sydney, Jane Foss Russell Building, Level 6, Sydney, NSW 2006, Australia (lucinda.grummitt@sydney.edu.au).
Author Contributions: Ms Grummitt and Mr Kreski had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Kreski, Keyes, McLaughlin.
Acquisition, analysis, or interpretation of data: Grummitt, Kreski, Kim, Platt.
Drafting of the manuscript: Grummitt, Kreski, Kim.
Critical revision of the manuscript for important intellectual content: Kreski, Platt, Keyes, McLaughlin.
Statistical analysis: Grummitt, Kreski, Platt, Keyes.
Administrative, technical, or material support: Keyes, McLaughlin.
Supervision: Keyes, McLaughlin.
Conflict of Interest Disclosures: Dr Keyes reported receiving personal fees from National Prescription Opioid Litigation K and testifying as an expert witness in litigation against opioid manufacturers and other defendants outside the submitted work. No other disclosures were reported.
Funding/Support: The current study was funded by grants R01-MH103291, R01-MH106482, and R37-MH119194 from the National Institute of Mental Health (Dr McLaughlin).
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.